Clinigen
the global Managed Access and Named Patient Supply leader, operating end-to-end EAPs that include regulatory oversight, logistics and access management; in 2026 it ran the Ionis zilganersen EAP for Alexander disease (NCT07487389, posted 23 March 2026),…
- Country
- United Kingdom
eu
managed-access
gxp
Coverage
| CN | EU | US | |
|---|---|---|---|
| market-access-commercial | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Named-patient programs & compassionate use | market-access-commercial | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.